Gillian Paine-Murrieta

Author

Also Known As

G D Paine-Murrieta, G Paine-Murrieta, G. Paine-Murrieta, G.D. Paine-Murrieta, Gillian D. Paine-Murrieta, Gillian Paine-Murrieta

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

University of Arizona Arizona Oncology University of Pittsburgh Sanford Burnham Prebys Medical Discovery Institute

About

Gillian Paine-Murrieta is an author at University of Arizona specializing in medicine, tumor biology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.6K
2	Natural Sciences	2	2	121
3	Biochemistry	2	2	121
4	Engineering	1	1	188
5	Biomedical Engineering	1	1	188

Gillian Paine-Murrieta

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Enhancement of chemotherapy by manipulation of tumour pH Natarajan Raghunand, Xi He, Robert van Sluis, British Journal of Cancer	1999	312
Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3-kinase signaling Nathan T. Ihle, Ryan Williams, Sherry Chow, Molecular Cancer Therapeutics	2004	311
Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha. Sarah J. Welsh, Ryan Williams, Lynn Kirkpatrick, PubMed Hypoxia-induced Hif-1alpha LevelsAntitumor ActivityChemoprevention StrategyImmunologyCell Death	2004	281
Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents. Rochelle Bagatell, Gillian Paine-Murrieta, Charles W. Taylor, PubMed ApoptosisCell DeathCytotoxic ActivityAntitumor Antibiotics GeldanamycinHsp90-binding Agents	2000	273
Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1α Sarah J. Welsh, Ryan Williams, Lynn Kirkpatrick, Molecular Cancer Therapeutics Hypoxia-induced Hif-1α LevelsAntitumor ActivityCell DeathPharmacotherapyCancer Biology	2004	242
Early Increases in Breast Tumor Xenograft Water Mobility in Response to Paclitaxel Therapy Detected by Non-Invasive Diffusion Magnetic Resonance Imaging Jean-Philippe Galons, María I. Altbach, Gillian Paine-Murrieta, Neoplasia Breast OncologyEngineeringOncologic ImagingBiomedical EngineeringPaclitaxel Therapy	1999	188
Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells. Alfred Gallegos, John R. Gasdaska, Charles W. Taylor, PubMed Cancer ResearchHuman Thioredoxin IncreasesDominant-negative Mutant ThioredoxinThioredoxin-transfected Mcf-7 CellsImmunology	1996	161
The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non–small cell lung cancer xenografts Nathan T. Ihle, Gillian Paine-Murrieta, Margareta Berggren, Molecular Cancer Therapeutics	2005	150
Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer. Rochelle Bagatell, Omar S. Khan, Gillian Paine-Murrieta, PubMed Breast OncologyPharmacotherapy90-Binding DrugsHormone ReceptorsSteroid Hormone Receptors	2001	119
Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents. Lars Engman, Ian A. Cotgreave, M. Martín Angulo, PubMed Thioredoxin SystemMedicinal ChemistryRedox Protein ThioredoxinPharmaceutical ChemistryChemoprevention Strategy	1998	95

Page 1